Acute lung injury pattern is a term originally coined by Katzenstein1 to encompass the entities of diffuse alveolar damage (DAD) and bronchiolitis obliterans-organizing pneumonia (BOOP). The term was meant to emphasize the relatively acute clinical onset of both entities, as well as the histologic temporal uniformity resultant from a single pulmonary insult occurring at a single moment in time. Both entities tend to show active fibroblastic proliferation rather than the dense collagen seen in more chronic processes. The term is also useful in the setting of small biopsies when precise classification may not be possible due to sampling issues. The term acute lung injury pattern as Katzenstein defined it refers to the pathologic findings, and should not be confused with the clinical definition of acute lung injury discussed below, although most patients with DAD fulfill the clinical definition as well.2


Acute Lung Injury Idiopathic Pulmonary Fibrosis Acute Respiratory Distress Syndrome Respir Crit Bronchiolitis Obliterans 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Katzenstein AL. Acute lung injury patterns: Diffuse alveolar damage and bronchiolitis-obliterans-organizing pneumonia. In: Katzenstein and Askin’s surgical pathology of non-neoplastic lung disease. Philadelphia: WB Saunders, 1997:14–47.Google Scholar
  2. 2.
    Carmichael LC, Dorinsky PM, Higgins SB, et al. Diagnosis and therapy of acute respiratory distress syndrome in adults: an international survey. J Crit Care 1996;11(1):9–18.PubMedGoogle Scholar
  3. 3.
    Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985;312(3):152–158.PubMedGoogle Scholar
  4. 4.
    Davison AG, Heard BE, McAllister WA, Turner-Warwick ME. Cryptogenic organizing pneumonitis. Q J Med 1983;52(207):382–394.PubMedGoogle Scholar
  5. 5.
    American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165(2):277–304.Google Scholar
  6. 6.
    Colby TV. Pathologic aspects of bronchiolitis obliterans organizing pneumonia. Chest 1992;102(1 suppl):38S–43S.PubMedGoogle Scholar
  7. 7.
    Travis WD, Colby T, Koss MN, Rosado de Christiansen ML, Muller NL, King TE Jr. Idiopathic interstitial pneumonia and other diffuse parenchymal lung disease. Nonneoplastic disorders of the lower respiratory tract. Washington, DC: Armed Forces Institute of Pathology, 2004.Google Scholar
  8. 8.
    Myers JL, Colby TV. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med 1993;14(4):611–622.PubMedGoogle Scholar
  9. 9.
    Cordier JF. Organising pneumonia. Thorax 2000;55(4):318–328.PubMedGoogle Scholar
  10. 10.
    Cordier JF. Cryptogenic organizing pneumonitis. Bronchiolitis obliterans organizing pneumonia. Clin Chest Med 1993;14(4):677–692.PubMedGoogle Scholar
  11. 11.
    King TE Jr, Mortenson RL. Cryptogenic organizing pneumonitis. The North American experience. Chest 1992;102(1 suppl):8S–13S.PubMedGoogle Scholar
  12. 12.
    Muller NL, Staples CA, Miller RR. Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. AJR 1990;154(5):983–987.PubMedGoogle Scholar
  13. 13.
    Lee KS, Kullnig P, Hartman TE, Muller NL. Cryptogenic organizing pneumonia: CT findings in 43 patients. AJR 1994;162(3):543–546.PubMedGoogle Scholar
  14. 14.
    Costabel U, Teschler H, Guzman J. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur Respir J 1992;5(7):791–797.PubMedGoogle Scholar
  15. 15.
    Kitaichi M. Differential diagnosis of bronchiolitis obliterans organizing pneumonia. Chest 1992;102(1 suppl):44S–49S.PubMedGoogle Scholar
  16. 16.
    Cohen AJ, King TE Jr, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med 1994;149(6):1670–1675.PubMedGoogle Scholar
  17. 17.
    Yousem SA, Lohr RH, Colby TV. Idiopathic bronchiolitis obliterans organizing pneumonia/cryptogenic organizing pneumonia with unfavorable outcome: pathologic predictors. Mod Pathol 1997;10(9):864–871.PubMedGoogle Scholar
  18. 18.
    Allen JN, Wewers MD. HIV-associated bronchiolitis obliterans organizing pneumonia. Chest 1989;96(1):197–198.PubMedGoogle Scholar
  19. 19.
    Carey CF, Mueller L, Fotopoulos CL, Dall L. Bronchiolitis obliterans-organizing pneumonia associated with Cryptococcus neoformans infection. Rev Infect Dis 1991;13(6):1253–1254.PubMedGoogle Scholar
  20. 20.
    Diehl JL, Gisselbrecht M, Meyer G, Israel-Biet D, Sors H. Bronchiolitis obliterans organizing pneumonia associated with chlamydial infection. Eur Respir J 1996;9(6):1320–1322.PubMedGoogle Scholar
  21. 21.
    Foley NM, Griffiths MH, Miller RF. Histologically atypical Pneumocystis carinii pneumonia. Thorax 1993;48(10):996–1001.PubMedGoogle Scholar
  22. 22.
    Goldstein JD, Godleski JJ, Balikian JP, Herman PG Pathologic patterns of Serratia marcescens pneumonia. Hum Pathol 1982;13(5):479–484.PubMedGoogle Scholar
  23. 23.
    Mayock DE, O’Rourke PP, Kapur RP. Bronchiolitis obliterans: a complication of group B streptococcal disease treated with extracorporeal membrane oxygenation. Pediatrics 1993;92(1):157–160.PubMedGoogle Scholar
  24. 24.
    Sato P, Madtes DK, Thorning D, Albert RK. Bronchiolitis obliterans caused by Legionella pneumophila. Chest 1985;87(6):840–842.PubMedGoogle Scholar
  25. 25.
    Yousem SA, Duncan SR, Griffith BP. Interstitial and airspace granulation tissue reactions in lung transplant recipients. Am J Surg Pathol 1992;16(9):877–884.PubMedGoogle Scholar
  26. 26.
    Miyagawa Y, Nagata N, Shigematsu N. Clinicopathological study of migratory lung infiltrates. Thorax 1991;46(4):233–238.PubMedGoogle Scholar
  27. 27.
    Camp M, Mehta JB, Whitson M. Bronchiolitis obliterans and Nocardia asteroides infection of the lung. Chest 1987;92(6):1107–1108.PubMedGoogle Scholar
  28. 28.
    Bridges AJ, Hsu KC, Dias-Arias AA, Chechani V. Bronchiolitis obliterans organizing pneumonia and scleroderma. J Rheumatol 1992;19(7):1136–1140.PubMedGoogle Scholar
  29. 29.
    Gammon RB, Bridges TA, al Nezir H, Alexander CB, Kennedy JI Jr. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest 1992;102(4):1171–1174.PubMedGoogle Scholar
  30. 30.
    Imasaki T, Yoshii A, Tanaka S, Ogura T, Ishikawa A, Takahashi T. Polymyositis and Sjogren’s syndrome associated with bronchiolitis obliterans organizing pneumonia. Intern Med 1996;35(3):231–235.PubMedGoogle Scholar
  31. 31.
    Ippolito JA, Palmer L, Spector S, Kane PB, Gorevic PD. Bronchiolitis obliterans organizing pneumonia and rheumatoid arthritis. Semin Arthritis Rheum 1993;23(1):70–78.PubMedGoogle Scholar
  32. 32.
    Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141(3):727–733.PubMedGoogle Scholar
  33. 33.
    Camus P, Lombard JN, Perrichon M, Piard F, Guerin JC, Thivolet FB et al. Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone. Thorax 1989;44(9):711–715.PubMedGoogle Scholar
  34. 34.
    Camus P, Piard F, Ashcroft T, Gal AA, Colby TV. The lung in inflammatory bowel disease. Medicine (Baltimore) 1993;72(3):151–183.Google Scholar
  35. 35.
    Hamadeh MA, Atkinson J, Smith LJ. Sulfasalazine-induced pulmonary disease. Chest 1992;101(4):1033–1037.PubMedGoogle Scholar
  36. 36.
    Rosenow EC III, Myers JL, Swensen SJ, Pisani RJ. Druginduced pulmonary disease. An update. Chest 1992;102(1):239–250.PubMedGoogle Scholar
  37. 37.
    Swinburn CR, Jackson GJ, Cobden I, Ashcroft T, Morritt GN, Corris PA. Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis. Thorax 1988;43(9):735–736.PubMedGoogle Scholar
  38. 38.
    van Laar JM, Holscher HC, van Krieken JH, Stolk J. Bronchiolitis obliterans organizing pneumonia after adjuvant radiotherapy for breast carcinoma. Respir Med 1997;91(4):241–244.PubMedGoogle Scholar
  39. 39.
    Tenholder MF, Becker GL, Cervoni MI. The myelodysplastic syndrome and bronchiolitis obliterans. Ann Intern Med 1990;112(9):714–715.PubMedGoogle Scholar
  40. 40.
    Watanabe K, Senju S, Wen FQ, Shirakusa T, Maeda F, Yoshida M. Factors related to the relapse of bronchiolitis obliterans organizing pneumonia. Chest 1998;114(6):1599–1606.PubMedGoogle Scholar
  41. 41.
    Siddiqui MT, Garrity ER, Husain AN. Bronchiolitis obliterans organizing pneumonia-like reactions: a nonspecific response or an atypical form of rejection or infection in lung allograft recipients? Hum Pathol 1996;27(7):714–719.PubMedGoogle Scholar
  42. 42.
    Mathew P, Bozeman P, Krance RA, Brenner MK, Heslop HE. Bronchiolitis obliterans organizing pneumonia (BOOP) in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;13(2):221–223.PubMedGoogle Scholar
  43. 43.
    Uner AH, Rozum-Slota B, Katzenstein AL. Bronchiolitis obliterans-organizing pneumonia (BOOP)-like variant of Wegener’s granulomatosis. A clinicopathologic study of 16 cases. Am J Surg Pathol 1996;20(7):794–801.PubMedGoogle Scholar
  44. 44.
    Domingo JA, Perez-Calvo JI, Carretero JA, Ferrando J, Cay A, Civeira F. Bronchiolitis obliterans organizing pneumonia. An unusual cause of solitary pulmonary nodule. Chest 1993;103(5):1621–1623.PubMedGoogle Scholar
  45. 45.
    Lohr RH, Boland BJ, Douglas WW, et al. Organizing pneumonia. Features and prognosis of cryptogenic, secondary, and focal variants. Arch Intern Med 1997;157(12):1323–1329.PubMedGoogle Scholar
  46. 46.
    Tomashefski JF Jr. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 2000;21(3):435–466.PubMedGoogle Scholar
  47. 47.
    Katzenstein AL, Myers JL, Prophet WD, Corley LS III, Shin MS. Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study. Am J Surg Pathol 1986;10(6):373–381.PubMedGoogle Scholar
  48. 48.
    Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18(2):136–147.PubMedGoogle Scholar
  49. 49.
    Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000;24(1):19–33.PubMedGoogle Scholar
  50. 50.
    Coleman A, Colby TV. Histologic diagnosis of extrinsic allergic alveolitis. Am J Surg Pathol 1988;12(7):514–518.PubMedGoogle Scholar
  51. 51.
    Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS. Surgical pathology of the lung in Wegener’s granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 1991;15(4):315–333.PubMedGoogle Scholar
  52. 52.
    Carrington CB, Addington WW, Goff AM, et al. Chronic eosinophilic pneumonia. N Engl J Med 1969;280(15):787–798.PubMedGoogle Scholar
  53. 53.
    Jederlinic PJ, Sicilian L, Gaensler EA. Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature. Medicine (Baltimore) 1988;67(3):154–162.Google Scholar
  54. 54.
    Beasley MB, Franks TJ, Galvin JR, Gochuico B, Travis WD. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 2002;126(9):1064–1070.PubMedGoogle Scholar
  55. 55.
    Gaudin PB, Askin FB, Falk RJ, Jennette JC. The pathologic spectrum of pulmonary lesions in patients with antineutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 1995;104(1):7–16.PubMedGoogle Scholar
  56. 56.
    Yoshinouchi T, Ohtsuki Y, Kubo K, Shikata Y. Clinicopathological study on two types of cryptogenic organizing pneumonitis. Respir Med 1995;89(4):271–278.PubMedGoogle Scholar
  57. 57.
    Ashbaugh DG, Bigelow DB, Petty TL. Acute Respiratory Distress in Adults. Lancet 1967;2:319–323.PubMedGoogle Scholar
  58. 58.
    Katzenstein AL, Bloor CM, Leibow AA. Diffuse alveolar damage—the role of oxygen, shock, and related factors. A review. Am J Pathol 1976;85(1):209–228.PubMedGoogle Scholar
  59. 59.
    Katzenstein AL, Myers JL, Mazur MT. Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 1986;10(4):256–267.PubMedGoogle Scholar
  60. 60.
    Hamman L, Rich A. Acute diffuse interstitial fibrosis of the lung. Bull Johns Hopkins Hosp 1944;74:177.Google Scholar
  61. 61.
    Olson J, Colby TV, Elliott CG Hamman-Rich syndrome revisited. Mayo Clin Proc 1990;65(12):1538–1548.PubMedGoogle Scholar
  62. 62.
    Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995;152(6 pt 1):1818–1824.PubMedGoogle Scholar
  63. 63.
    Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342(18):1334–1349.PubMedGoogle Scholar
  64. 64.
    Hudson LD, Steinberg KP. Epidemiology of acute lung injury and ARDS. Chest 1999;116(1 suppl):74S–82S.PubMedGoogle Scholar
  65. 65.
    Luhr OR, Antonsen K, Karlsson M, et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group. Am J Respir Crit Care Med 1999;159(6):1849–1861.PubMedGoogle Scholar
  66. 66.
    Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983–1993. JAMA 1995;273(4):306–309.PubMedGoogle Scholar
  67. 67.
    Goss CH, Brower RG, Hudson LD, Rubenfeld GD. Incidence of acute lung injury in the United States. Crit Care Med 2003;31(6):1607–1611.PubMedGoogle Scholar
  68. 68.
    Tagliabue M, Casella TC, Zincone GE, Fumagalli R, Salvini E. CT and chest radiography in the evaluation of adult respiratory distress syndrome. Acta Radiol 1994;35(3):230–234.PubMedGoogle Scholar
  69. 69.
    Yazdy AM, Tomashefski JF Jr, Yagan R, Kleinerman J. Regional alveolar damage (RAD). A localized counterpart of diffuse alveolar damage. Am J Clin Pathol 1989;92(1):10–15.PubMedGoogle Scholar
  70. 70.
    Churg A, Golden J, Fligiel S, Hogg JC. Bronchopulmonary dysplasia in the adult. Am Rev Respir Dis 1983;127(1):117–120.PubMedGoogle Scholar
  71. 71.
    Nash G, Foley FD, Langlinais PC. Pulmonary interstitial edema and hyaline membranes in adult burn patients. Electron microscopic observations. Hum Pathol 1974;5(2):149–160.PubMedGoogle Scholar
  72. 72.
    Tomashefski JF Jr, Davies P, Boggis C, Greene R, Zapol WM, Reid LM. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol 1983;112(1):112–126.PubMedGoogle Scholar
  73. 73.
    Pratt PC. Pathology of adult respiratory distress syndrome. Monogr Pathol 1978;19:43–57.PubMedGoogle Scholar
  74. 74.
    Tomashefski JF Jr. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 2000;21(3):435–466.PubMedGoogle Scholar
  75. 75.
    Patel SR, Karmpaliotis D, Ayas NT, et al. The role of open-lung biopsy in ARDS. Chest 2004;125(1):197–202.PubMedGoogle Scholar
  76. 76.
    Pugin J, Verghese G, Widmer MC, Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 1999;27(2):304–312.PubMedGoogle Scholar
  77. 77.
    Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990;142(6 pt 1):1250–1257.PubMedGoogle Scholar
  78. 78.
    Sznajder JI. Strategies to increase alveolar epithelial fluid removal in the injured lung. Am J Respir Crit Care Med 1999;160(5 pt 1):1441–1442.PubMedGoogle Scholar
  79. 79.
    Greene KE, Wright JR, Steinberg KP, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999;160(6):1843–1850.PubMedGoogle Scholar
  80. 80.
    Glauser FL, Fairman RP. The uncertain role of the neutrophil in increased permeability pulmonary edema. Chest 1985;88(4):601–607.PubMedGoogle Scholar
  81. 81.
    Laufe MD, Simon RH, Flint A, Keller JB. Adult respiratory distress syndrome in neutropenic patients. Am J Med 1986;80(6):1022–1026.PubMedGoogle Scholar
  82. 82.
    Goodman RB, Strieter RM, Martin DP, et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154(3 pt 1):602–611.PubMedGoogle Scholar
  83. 83.
    Hasleton PS, Roberts TE. Adult respiratory distress syndrome-an update. Histopathology 1999;34(4):285–294.PubMedGoogle Scholar
  84. 84.
    Martinet Y, Menard O, Vaillant P, Vignaud JM, Martinet N. Cytokines in human lung fibrosis. Arch Toxicol Suppl 1996;18:127–139.PubMedGoogle Scholar
  85. 85.
    Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TR. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 1996;153(6 pt 1):1850–1856.PubMedGoogle Scholar
  86. 86.
    Parsons PE, Moore FA, Moore EE, Ikle DN, Henson PM, Worthen GS. Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am Rev Respir Dis 1992;146(3):694–700.PubMedGoogle Scholar
  87. 87.
    Fisher CJ Jr, Agosti JM, Opal SM, et al. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996;334(26):1697–1702.PubMedGoogle Scholar
  88. 88.
    Donnelly SC, Haslett C, Reid PT, et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997;3(3):320–323.PubMedGoogle Scholar
  89. 89.
    El Gamel A, Awad M, Sim E, et al. Transforming growth factor-betal and lung allograft fibrosis. Eur J Cardiothorac Surg 1998;13(4):424–430.PubMedGoogle Scholar
  90. 90.
    Gunther A, Mosavi P, Heinemann S, et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000;161(2 pt 1):454–462.PubMedGoogle Scholar
  91. 91.
    Idell S, James KK, Levin EG, et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989;84(2):695–705.PubMedGoogle Scholar
  92. 92.
    Hayashi T, Stetler-Stevenson WG, Fleming MV, et al. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 1996;149(4):1241–1256.PubMedGoogle Scholar
  93. 93.
    Slutsky AS, Tremblay LN. Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 1998;157(6 pt 1):1721–1725.PubMedGoogle Scholar
  94. 94.
    Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988;137(5):1159–1164.PubMedGoogle Scholar
  95. 95.
    Tazelaar HD, Linz LJ, Colby TV, Myers JL, Limper AH. Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am J Respir Crit Care Med 1997;155(1):296–302.PubMedGoogle Scholar
  96. 96.
    Ambrosini V, Cancellieri A, Chilosi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J 2003;22(5):821–826.PubMedGoogle Scholar
  97. 97.
    Travis WD, Colby TV, Lombard C, Carpenter HA. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990;14(12):1112–1125.PubMedGoogle Scholar
  98. 98.
    Abel SJ, Finney SJ, Brett SJ, Keogh BF, Morgan CJ, Evans TW. Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax 1998;53(4):292–294.PubMedGoogle Scholar
  99. 99.
    Sloane PJ, Gee MH, Gottlieb JE, et al. A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. Am Rev Respir Dis 1992;146(2):419–426.PubMedGoogle Scholar
  100. 100.
    Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987;317(25):1565–1570.PubMedGoogle Scholar
  101. 101.
    Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988;138(1):62–68.PubMedGoogle Scholar
  102. 102.
    Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996;334(22):1417–1421.PubMedGoogle Scholar
  103. 103.
    Dellinger RP, Zimmerman JL, Taylor RW, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998;26(1):15–23.PubMedGoogle Scholar
  104. 104.
    Flick MR, Matthay MA. Pulmonary edema and acute lung injury. In: Murray JF, Nadel JA, eds. Textbook of respiratory medicine. 3rd ed. Philadelphia: WB Saunders, 2000:1575.Google Scholar
  105. 105.
    Schoene RB, Hackett PH, Hornbein TF. High altitude. In: Murray JF, Nadel JA, eds. Textbook of respiratory medicine. 3rd ed. Philadelphia: WB Saunders, 2000:1915–1950.Google Scholar
  106. 106.
    Houston CS. Acute pulmonary edema of high altitude. N Engl J Med 1960;263:478–480.PubMedGoogle Scholar
  107. 107.
    Marticorena E, Tapia FA, Dyer J, et al. Pulmonary edema by ascending to high altitudes. Dis Chest 1964;45:273–283.PubMedGoogle Scholar
  108. 108.
    Menon ND. High altitude pulmonary edema. N Engl J Med 1965;273:66–73.PubMedGoogle Scholar
  109. 109.
    Hultgren HN, Spickard WB, Hellriegel J, Houston CS. High altitude pulmonary oedema. Medicine (Baltimore) 1961;40:289–313.Google Scholar
  110. 110.
    Heath D, Williams DR. High altitude pulmonary oedema. Man at high altitude. The pathophysiology of acclimatization and adaptation. Edinburgh: Churchill Livingston, 1977:121–136.Google Scholar
  111. 111.
    Singh I, Kapila CC, Khanna PK, Nanda RB, Rao BDP High altitude pulmonary edema. Lancet 1965;191:229–234.Google Scholar
  112. 112.
    Arias-Stella J, Kruger H. Pathology of high altitude pulmonary edema. Arch Pathol 1963;76:147.PubMedGoogle Scholar
  113. 113.
    Nayak NC, Roy S, Narayaran TK. Pathologic features of altitude sickness. Am J Pathol 1964;45:381–391.PubMedGoogle Scholar
  114. 114.
    Heath D, Moosavi H, Smith P. Ultrastructure of high altitude pulmonary oedema. Thorax 1973;28:694–700.PubMedGoogle Scholar
  115. 115.
    Hanaoka M, Kubo K, Yamazaki Y. Association of high altitude pulmonary edema with the major histocompatibility complex. Circulation 1998;97:1124–1128.PubMedGoogle Scholar
  116. 116.
    Kaminsky DA, Jones K, Schoene RB. Urinary leukotriene E4 levels in high-altitude pulmonary edema. A possible role for inflammation. Chest 1996;11:939–945.Google Scholar
  117. 117.
    Oelz O, Maggiorini M, Ritter M. Nifedipine for high altitude pulmonary edema. Lancet 1989;2:1241–1244.PubMedGoogle Scholar
  118. 118.
    Colice GL, Matthay MA, Bass E, Matthay RA. Neurogenic pulmonary edema. Am Rev Respir Dis 1984;130:941–948.PubMedGoogle Scholar
  119. 119.
    Sautter RD, Dreher WH, MacIndoe JH, Myers WO, Magnin GE. Fatal pulmonary edema and pneumonitis after re-expansion of chronic pneumothorax. Chest 1971;60:399–401.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Mary Beth Beasley
    • 1
  1. 1.Department of PathologyProvidence Portland Medical CenterPortlandUSA

Personalised recommendations